According to Y-mAbs Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.99992. At the end of 2023 the company had a P/S ratio of 3.51.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.51 | 7.42% |
2022 | 3.27 | -83.89% |
2021 | 20.3 | -79.03% |
2020 | 96.7 | |
2019 | N/A | |
2018 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |